Engineered immune cells trial to fight colorectal cancer approved
Elix and Axcelead DDP to collaborate on targeted protein degrader discovery
Lotus Neuro launches to deliver therapies across blood-brain barrier
Antibody targeting TSLP achieves positive results in asthma study
KTU chemists develop dual-action compounds to fight cancer
RSV antiviral drug receives FDA approval for phase II trial
Research uncovers new driver of immunotherapy resistance in pancreatic cancer
Pilot project between BioCytics and LIDE Biotech
IASO acquires cell therapy company MediSix
Jazz Pharmaceuticals to acquire Actio Biosciences and expand rare epilepsy portfolio
Tagomics introduces cfDNA-based blood test for multi-organ drug safety monitoring
Base to Base biotech podcast 71: The IgA/CD89 axis